Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients

Metabolism: Clinical and Experimental

Volumn 60, Issue 1, 2011, Pages 121-126

  Park, Jung Tak ^a   Yoo, Tae Hyun ^a   Chang, Tae Ik ^a   Lee, Dong Hyung ^a   Lee, Joo Hyun ^a   Lee, Jung Eun ^a   Choi, Hoon Young ^a   Kang, Shin Wook ^a   Han, Dae Suk ^a   Ryu, Dong Ryeol ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLADDER CANCER; CANCER RISK; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY CANCER; KIDNEY FAILURE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; STOMACH CANCER; THYROID CANCER; URETER CANCER;

ADIPONECTIN; ADULT; AGED; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEOPLASMS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROSPECTIVE STUDIES;

EID: 78649952873     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.02.006     Document Type: Article

References (40)

1. Iseki K., Osawa A., and Fukiyama K. Evidence for increased cancer deaths in chronic dialysis patients Am J Kidney Dis 22 1993 308 313
2. Matas A.J., Simmons R.L., and Kjellstrand C.M. Increased incidence of malignancy during chronic renal failure Lancet 1 1975 883 886
3. Maisonneuve P., Agodoa L., and Gellert R. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Lancet 354 1999 93 99
4. Vamvakas S., Bahner U., and Heidland A. Cancer in end-stage renal disease: potential factors involved-editorial Am J Nephrol 18 1998 89 95
5. Vamvakas S., Bahner U., and Becker P. Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation Transplant Proc 28 1996 3468 3473
6. Calle E.E., Rodriguez C., and Walker-Thurmond K. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
7. Barb D., Williams C.J., and Neuwirth A.K. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am J Clin Nutr 86 2007 s858 s866
8. Dossus L., and Kaaks R. Nutrition, metabolic factors and cancer risk Best Pract Res Clin Endocrinol Metab 22 2008 551 571
9. DeFronzo R.A., Alvestrand A., and Smith D. Insulin resistance in uremia J Clin Invest 67 1981 563 568
10. Fliser D., Pacini G., and Engelleiter R. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease Kidney Int 53 1998 1343 1347
11. Fortes P.C., de Moraes T.P., and Mendes J.G. Insulin resistance and glucose homeostasis in peritoneal dialysis Perit Dial Int 29 Suppl 2 2009 S145 S148
12. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20 1997 1183 1197
13. Wong G., Hayen A., and Chapman J.R. Association of CKD and cancer risk in older people J Am Soc Nephrol 20 2009 1341 1350
14. 2005 Annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals 2008 Ministry of Health and Welfare Seoul (Korea)
15. Levine E. Renal cell carcinoma in uremic acquired renal cystic disease: incidence, detection, and management Urol Radiol 13 1992 203 210
16. Marple J.T., MacDougall M., and Chonko A.M. Renal cancer complicating acquired cystic kidney disease J Am Soc Nephrol 4 1994 1951 1956
17. Noronha I.L., Ritz E., and Waldherr R. Renal cell carcinoma in dialysis patients with acquired renal cysts Nephrol Dial Transplant 4 1989 763 769
18. Calle E.E., and Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 2004 579 591
19. Friberg E., Orsini N., and Mantzoros C.S. Diabetes mellitus and risk of endometrial cancer: a meta-analysis Diabetologia 50 2007 1365 1374
20. Huxley R., Ansary-Moghaddam A., and Berrington de Gonzalez A. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies Br J Cancer 92 2005 2076 2083
21. Larsson S.C., Mantzoros C.S., and Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis Int J Cancer 121 2007 856 862
22. Larsson S.C., Orsini N., and Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis J Natl Cancer Inst 97 2005 1679 1687
23. Mori M., Saitoh S., and Takagi S. A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer Asian Pac J Cancer Prev 1 2000 269 276
24. Pollack M.N. Insulin, insulin-like growth factors, insulin resistance, and neoplasia Am J Clin Nutr 86 2007 s820 s822
25. Adrogue H.J. Glucose homeostasis and the kidney Kidney Int 42 1992 1266 1282
26. de Moraes T.P., and Pecoits-Filho R. Metabolic impact of peritoneal dialysis Contrib Nephrol 163 2009 117 123
27. Michalakis K., Williams C.J., and Mitsiades N. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study Cancer Epidemiol Biomarkers Prev 16 2007 308 313
28. Spyridopoulos T.N., Petridou E.T., and Skalkidou A. Low adiponectin levels are associated with renal cell carcinoma: a case-control study Int J Cancer 120 2007 1573 1578
29. Tworoger S.S., Eliassen A.H., and Kelesidis T. Plasma adiponectin concentrations and risk of incident breast cancer J Clin Endocrinol Metab 92 2007 1510 1516
30. Wei E.K., Giovannucci E., and Fuchs C.S. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study J Natl Cancer Inst 97 2005 1688 1694
31. Bub J.D., Miyazaki T., and Iwamoto Y. Adiponectin as a growth inhibitor in prostate cancer cells Biochem Biophys Res Commun 340 2006 1158 1166
32. Zoccali C., Mallamaci F., and Tripepi G. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease J Am Soc Nephrol 13 2002 134 141
33. Zoccali C., Mallamaci F., and Tripepi G. Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease Kidney Int Suppl 2003 S65 S68
34. Teta D., Maillard M., and Halabi G. The leptin/adiponectin ratio: potential implications for peritoneal dialysis Kidney Int Suppl 2008 S112 S118
35. Furuya R., Odamaki M., and Kumagai H. Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients Nephrol Dial Transplant 21 2006 494 498
36. Margolis K.L., Rodabough R.J., and Thomson C.A. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women Arch Intern Med 167 2007 1837 1844
37. Ouchi N., and Walsh K. Adiponectin as an anti-inflammatory factor Clin Chim Acta 380 2007 24 30
38. Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance J Clin Invest 116 2006 1793 1801
39. Ohshima H., Tazawa H., and Sylla B.S. Prevention of human cancer by modulation of chronic inflammatory processes Mutat Res 591 2005 110 122
40. ter Wee P.M., and van Ittersum F.J. The new peritoneal dialysis solutions: friends only, or foes in part? Nat Clin Pract Nephrol 3 2007 604 612